Concepts (45)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 4 | 2007 | 304 | 0.360 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2019 | 1 | 0.150 |
Why?
|
| Critical Care | 1 | 2019 | 49 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 46 | 0.140 |
Why?
|
| Hospitalization | 1 | 2019 | 207 | 0.130 |
Why?
|
| Prostatectomy | 2 | 2007 | 90 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2019 | 632 | 0.120 |
Why?
|
| Prostate-Specific Antigen | 2 | 2007 | 54 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 2 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2007 | 15 | 0.070 |
Why?
|
| Seminal Vesicles | 1 | 2007 | 5 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2007 | 14 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 681 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 2007 | 95 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 126 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 191 | 0.060 |
Why?
|
| Mass Screening | 1 | 2007 | 160 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2007 | 247 | 0.060 |
Why?
|
| Male | 5 | 2019 | 14120 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 346 | 0.050 |
Why?
|
| Aged | 2 | 2007 | 5647 | 0.040 |
Why?
|
| Oregon | 1 | 2019 | 11 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 22 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 63 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2019 | 125 | 0.030 |
Why?
|
| Humans | 5 | 2019 | 29202 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 105 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 903 | 0.030 |
Why?
|
| Haplotypes | 2 | 2007 | 290 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 1066 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1213 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2007 | 557 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 2144 | 0.020 |
Why?
|
| Child | 1 | 2019 | 2354 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2659 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 3254 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 48 | 0.020 |
Why?
|
| Europe | 1 | 2007 | 100 | 0.020 |
Why?
|
| Genomics | 1 | 2007 | 126 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 741 | 0.010 |
Why?
|
| African Americans | 1 | 2007 | 353 | 0.010 |
Why?
|
| Female | 1 | 2019 | 15819 | 0.010 |
Why?
|
| United States | 1 | 2007 | 2269 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 7493 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 8125 | 0.010 |
Why?
|